| dc.contributor | Londoño Patiño, John Darío | |
| dc.contributor | Ovalle Oñate, Rafael | |
| dc.contributor | De Zubiría, Alberto | |
| dc.contributor | Bello Gualtero, Juan Manuel | |
| dc.contributor | Jaimes Fernández, Diego Alejandro | |
| dc.date.accessioned | 2012-08-15T17:24:25Z | |
| dc.date.available | 2012-08-15T17:24:25Z | |
| dc.date.created | 2012-08-15T17:24:25Z | |
| dc.date.issued | 2012-08-15 | |
| dc.identifier | Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the
epidemiology and progression of systemic lupus erythematosus. Semin Arthritis
Rheum. 2010; 39:257-68. | |
| dc.identifier | Tikly M, Navarra SV. Lupus in the developing world is it any different? Best Pract Res
Clin Rheumatol. 2008; 22:643-55. | |
| dc.identifier | Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008; 358:929-
39. | |
| dc.identifier | Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin
Rheumatol. 2002; 16:847-58. | |
| dc.identifier | McCarty DJ, Manzi S, Medsger TA, Jr., Ramsey-Goldman R, LaPorte RE, Kwoh CK.
Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis
Rheum. 1995; 38:1260-70. | |
| dc.identifier | McAlindon T. Update on the epidemiology of systemic lupus erythematosus: new spins
on old ideas. Curr Opin Rheumatol. 2000; 12:104-12. | |
| dc.identifier | Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus
erythematosus? Int J Clin Pract. 2007; 61:1170-80. | |
| dc.identifier | Jimenez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus
erythematosus. Clin Rev Allergy Immunol. 2003; 25:3-12. | |
| dc.identifier | Isenberg D, Bacon P, Bombardier C, Gladman D, Goldsmith CH, Kalunian K, et al.
Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol.
1989;16:1395-6 | |
| dc.identifier | Chang E, Abrahamowicz M, Ferland D, Fortin PR. Comparison of the responsiveness of
lupus disease activity measures to changes in systemic lupus erythematosus activity
relevant to patients and physicians. J Clin Epidemiol. 2002; 55:488- 97. | |
| dc.identifier | Gladman D, Urowitz M, Kagal A, Hallet D. Accurately describing changes in disease
activity in systemic lupus erythematosus. J Rheum. 2000; 27:377-9. | |
| dc.identifier | Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus
erythematosus and the use of lupus disease activity indices. Best Pract Res Clin
Rheumatol. 2005; 19:685-708. | |
| dc.identifier | Yee CS, McElhone K, Teh LS, Gordon C. Assessment of disease activity and quality of
life in systemic lupus erythematosus - New aspects. Best Pract Res Clin Rheumatol.
2009; 23:457-67. | |
| dc.identifier | Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, et al. European
League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis.
2010; 69:1269-74. | |
| dc.identifier | Alarcon GS, Calvo-Alen J, McGwin G, Jr., Uribe AG, Toloza SM, Roseman JM, et al.
Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive
factors of high disease activity over time. Ann Rheum Dis. 2006; 65:1168-74. | |
| dc.identifier | Fernandez M, Calvo-Alen J, Alarcon GS, Roseman JM, Bastian HM, Fessler BJ, et al.
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease
activity, damage accrual, and vascular events in pre- and postmenopausal women.
Arthritis Rheum. 2005; 52:1655-64. | |
| dc.identifier | Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA. Definition and treatment of lupus
flares measured by the BILAG index. Rheumatology. 2003; 42:1372-9. | |
| dc.identifier | Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI.
A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
Arthritis Rheum. 1992; 35:630-40. | |
| dc.identifier | . Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Bombardieri S.
Disease activity in systemic lupus erythematosus: report of the Consen- sus Study
Group of the European Workshop for Rheumatology Research. III. Development of a
computerised clinical chart and its application to the comparison of different indices of
disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin
Exp Rheumatol. 1992; 10:549-54. | |
| dc.identifier | Gladman D, Ibanez D, Urowitz M. Systemic lupus erythematosus activity index 2000. J
Rheumatol. 2002; 29:288-91. | |
| dc.identifier | Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for
the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis
Rheum. 1989; 32:1107-18. | |
| dc.identifier | Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The
development and initial validation of the Systemic Lupus International Collaborating
Clinics/American College of Rheumatology damage index for systemic lupus
erythematosus. Arthritis Rheum. 1996; 39:363-9. | |
| dc.identifier | Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and
experience in the field. Lupus. 1999; 8:632-7. | |
| dc.identifier | Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by
the SLICC/ACR damage index is a predictor of mortality in systemic lupus
erythematosus. Lupus. 2001; 10:93-96. | |
| dc.identifier | . Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response.Qual
Life Res. 2001; 10:405-13 | |
| dc.identifier | Almehed K, Carlsten H, Forsblad-d'Elia H. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability. Scand J
Rheumatol. 2010; 39:58-62. | |
| dc.identifier | Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The
GLADEL multinational Latin American prospective inception cohort of 1,214 patients
with systemic lupus erythematosus: ethnic and disease heterogeneity among
"Hispanics". Medicine (Baltimore). 2004; 83:1-17. | |
| dc.identifier | Alarcón GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, et al. Systemic
lupus erythematosus in three ethnic groups: III. A comparison of characteristics early
in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs.
Nurture. Lupus. 1999; 8:197-209. | |
| dc.identifier | Isenberg DA, Allen E, Farewell V, D'Cruz D, Alarcón GS, Aranow C, et al. An assessment
of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG
2004 and the flare version of SELENA. Ann Rheum Dis. 2011; 70:54-9. | |
| dc.identifier | Pope J. The revised BILAG Index with numerical scoring in systemic lupus
erythematosus: added value with some limitations.Rheumatology (Oxford). 2010;
49:1616-7. | |
| dc.identifier | Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring
for the BILAG-2004 index. Rheumatology (Oxford). 2010; 49:1665-9 | |
| dc.identifier | Furie RA, Petri MA, Wallace DJ, Ginzler EM, Merrill JT, Stohl W, et al. Novel evidencebased
systemic lupus erythematosus responder index. Arthritis Rheum. 2009; 61:1143-
51. | |
| dc.identifier | Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis
Clin North Am. 2005; 31:245-54 | |
| dc.identifier | Ruiz O, Londoño J; Velez P; Ortiz I; Motta L; Valle-Oñate R. Descripcion de una cohorte
de pacientes con Lupus Eritematoso Sistemico (LES) en un Hospital de BogotaColombia. Rev Colomb Rumatol. 2003; 10:266-76. | |
| dc.identifier | Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, et al. Systemic lupus
erythematosus in males. A study of 107 Latin American patients. Medicine (Baltimore).
1996; 75:124-30. | |
| dc.identifier | Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition
of risk factors for death, end stage renal disease, and thromboembolic events in a
monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum
Dis. 2002; 61:1065-70 | |
| dc.identifier | Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male
systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients.
Lupus. 2005; 14:938-46 | |
| dc.identifier | Pinto L VC, Márquez Y. Subgrupos de Lupus Eritematoso Sistémico: influencia de la
edad de inicio, la raza, el sexo y el perfil de anticuerpos en las manifestaciones clínicas
de la enfermedad. Rev Col Reumatol. 2008; 15:291-8 | |
| dc.identifier | Hsu CY, Pu C, Sewell KL. Systemic lupus erythematosus as a cause of failure to thrive in
older people. J Am Geriatr Soc.1996; 44:337-8. | |
| dc.identifier | Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Lanzoni VP, Ferraz ML, Silva AE.
Late-onset systemic lupus erythematosus-associated liver disease. Rheumatol Int.
2010 Apr 8. [Epub ahead of print] | |
| dc.identifier | Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a
predominantly Chinese population. J Rheumatol. 1994; 21:1463-7. | |
| dc.identifier | González LA, Ramírez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb
Reumatol. 2008; 15:168-85. | |
| dc.identifier | Gaviria L, Rodelo J , Uribe O , Vásquez G, Ramírez L Características clínicas y
serológicas de los pacientes con LES de inicio tardío en una población colombiana.
Rev Colomb Reumatol. 2007; 14: 23-31 | |
| dc.identifier | Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren's syndrome in
systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010;
37:1143-9. | |
| dc.identifier | Toloza SM, Jolly M, Alarcón GS. Quality-of-life measurements in multiethnic patients
with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010;
12:237-49 | |
| dc.identifier | Drenkard C, Alarcon-Segovia D. The new prognosis of systemic lupus erythematosus:
treatment-free remission and decreased mortality and morbidity. Isr Med Assoc J.
2000; 2:382-7. | |
| dc.identifier | Duran S, Gonzalez LA, Alarcon GS. Damage, accelerated atherosclerosis, and mortality
in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US
cohort. J Clin Rheumatol. 2007; 13:350-3 | |
| dc.identifier | Lalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus.
Clinical features and prognosis of late-onset systemic lupus erythematosus: results
from the 1000 faces of lupus study. J Rheumatol. 2010 ;37:38-44 | |
| dc.identifier | Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship
between the disease activity and damage in patients with systemic lupus
erythematosus a 5 year prospective study. Rheumatology. 2004; 43:1039-44 | |
| dc.identifier | Stoll T, Seifert B, Isenberg D. ACR/SLICC damage index is a useful predictor of severe
outcome in SLE patients and an indicator of morbidity in different ethnic groups. Brit J
Rheumatol. 1996; 35:248-54. | |
| dc.identifier | Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of
British patients with systemic lupus erythematosus followed up for over 10 years.
Rheumatology (Oxford). 2009; 48:673-5 | |
| dc.identifier | Alarcón GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA,
Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in
three ethnic groups. XX. Damage as a predictor of further damage Rheumatology
(Oxford). 2004; 43:202-5. | |
| dc.identifier | Gilboe IM, Kvien TK, Husby G. Disease course in systemic lupus erythematosus:
changes in health status, disease activity, J Rheumatol. 2001; 28:266-74 | |
| dc.identifier | Yazdany J, Yelin E. Health-Related Quality of Life and Employment Among Persons
with Systemic Lupus Erythematosus . Rheum Dis Clin North Am. 2010; 36: 15–32. | |
| dc.identifier | Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al.
Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors
of self-reported health-related quality of life early in the disease course. Arthritis
Rheum. 2004; 51:465-74. | |
| dc.identifier | http://hdl.handle.net/10818/3418 | |
| dc.identifier | 152672 | |
| dc.identifier | TE00273 | |
| dc.description.abstract | Objetivo. Características de LES en Colombianos. Métodos. Corte transversal. Resultados. 109 pacientes; Mujeres 91.7%; Edad media diagnóstico 30,6±12,5 años. Artritis (61,5%), alopecia (59,6%) pérdida de peso (54,1%), proteinuria (34,9 %), xeroftalmia (33 %), xerostomía (28,4 %), trombocitopenia (27,5%) y S. Sjögren (21,1%) mas frecuentes. BILAG: Leve (45,9%), moderada (3,5%) y severa ( 27,5%). SLICC/ACR: 50 (45,8%). SF36: ≤50 ( 83,5% y 74,3%) y ≥51 (16,5% y 30,2%) en dominios salud física y salud mental. Correlación moderada e inversa: Estrato socioeconómico (-0,41), nivel educativo (-0,36) y daño orgánico; Correlación débil: SF 36 componente físico (-0,21) y daño orgánico. Conclusiones: Hay alta frecuencia de S. de Sjögren. Hay correlación significativa con nivel educativo, estrato socioeconómico y peor función física con daño orgánico. | |
| dc.language | spa | |
| dc.publisher | Universidad de La Sabana | |
| dc.publisher | Especialización en Medicina Interna | |
| dc.publisher | Facultad de Medicina | |
| dc.rights | openAccess | |
| dc.source | Universidad de La Sabana | |
| dc.source | Intellectum Repositorio Universidad de La Sabana | |
| dc.subject | Lupus eritematoso sistémico-Investigaciones | |
| dc.subject | Lupus eritematoso sistémico-Epidemiología-Investigaciones | |
| dc.subject | Lupus eritematoso sistémico-Patología-Investigaciones | |
| dc.subject | Lupus eritematoso sistémico-Clases sociales-Investigaciones | |
| dc.title | Características medio-ambientales, de actividad, cronicidad y calidad de vida de los pacientes con lupus eritematoso sistémico atendidos en dos hospitales universitarios de Bogotá | |
| dc.type | bachelorThesis | |
